Skip to main content
. Author manuscript; available in PMC: 2016 May 18.
Published in final edited form as: Bone Marrow Transplant. 2015 Aug 24;50(12):1513–1518. doi: 10.1038/bmt.2015.190

Table 3.

Adjusted probabilities of outcomes

GF* CC+GF* P
Non relapse mortality
1–year 2 (1–4)% 1 (1–3)% 0.42
2–year 3 (1–4)% 2 (1–3)% 0.32
3–year 3 (1–4)% 2 (1–4)% 0.54
4–year 4 (2–6)% 3 (2–6)% 0.64
5–year 4 (2–6)% 3 (2–6)% 0.64
Progression-free survival
1–year 77 (73–81)% 79 (74–82)% 0.62
2–year 57 (52–61)% 62 (57–67)% 0.13
3–year 43 (38–48)% 40 (35–45)% 0.33
4–year 31 (26–37)% 31 (26–36)% 0.85
5–year 19 (13–25)% 26 (20–32)% 0.11
Overall survival
1–year 95 (92–96)% 92 (89–94)% 0.10
2–year 88 (84–90)% 85 (82–89)% 0.37
3–year 82 (78–86)% 80 (75–84)% 0.43
4–year 73 (68–78)% 71 (65–76)% 0.54
5–year 62 (54–68)% 60 (52–67)% 0.76
*

Percentage ( 95% confidence interval)